• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020.

作者信息

Rao Krishna, Malani Preeti N

机构信息

Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.

Associate Editor.

出版信息

JAMA. 2020 Apr 14;323(14):1403-1404. doi: 10.1001/jama.2019.3849.

DOI:10.1001/jama.2019.3849
PMID:32150234
Abstract
摘要

相似文献

1
Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020.2020年成人艰难梭菌感染的诊断与治疗
JAMA. 2020 Apr 14;323(14):1403-1404. doi: 10.1001/jama.2019.3849.
2
Clinical Guideline Highlights for the Hospitalist: Diagnosis and Management of Clostridium difficile in Adults.医院医生临床指南要点：成人艰难梭菌的诊断与管理
J Hosp Med. 2020 Feb 1;15(2):95-96. doi: 10.12788/jhm.3300. Epub 2019 Sep 18.
3
Diagnosis and Treatment of Clostridium difficile Infection.艰难梭菌感染的诊断与治疗
JAMA. 2018 Sep 11;320(10):1031-1032. doi: 10.1001/jama.2018.12194.
4
Fidaxomicin for the treatment of in children. fidaxomicin 治疗儿童。
Future Microbiol. 2020 Jul;15(11):967-979. doi: 10.2217/fmb-2020-0104. Epub 2020 Jul 27.
5
[Clostridioides difficile infection: various therapeutic approaches].[艰难梭菌感染：多种治疗方法]
Rev Med Suisse. 2022 Oct 12;18(799):1896-1899. doi: 10.53738/REVMED.2022.18.799.1896.
6
Successful Fidaxomicin Hospital Discharges of Adult Patients With Clostridioides difficile Infections Post-2021 Guidelines: Are Economic Barriers Finally Coming Down?2021 年指南发布后，成功使用非达霉素对成年艰难梭菌感染患者进行医院出院治疗：经济障碍是否终于消除？
Clin Infect Dis. 2022 Aug 31;75(3):519-521. doi: 10.1093/cid/ciab1061.
7
Management of Clostridioides difficile Infection: Diagnosis, Treatment, and Future Perspectives.艰难梭菌感染的管理：诊断、治疗及未来展望
Am J Med. 2024 Jul;137(7):571-576. doi: 10.1016/j.amjmed.2024.03.024. Epub 2024 Mar 18.
8
The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin.艰难梭菌定植小鼠经万古霉素和非达霉素治疗后的肠道微生物多样性。
J Infect Chemother. 2020 May;26(5):483-491. doi: 10.1016/j.jiac.2019.12.020. Epub 2020 Mar 9.
9
Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile.口服甲硝唑、万古霉素和非达霉素对艰难梭菌宿主脱落和环境污染的影响。
Clin Infect Dis. 2022 Mar 1;74(4):648-656. doi: 10.1093/cid/ciab473.
10
Cost-effectiveness analysis of fidaxomicin for the treatment of Clostridioides (Clostridium) difficile infection in Japan.费迪霉素治疗日本艰难梭菌（梭状芽孢杆菌）感染的成本效果分析。
J Infect Chemother. 2020 Jun;26(6):611-618. doi: 10.1016/j.jiac.2020.01.018. Epub 2020 Mar 9.

引用本文的文献

1
Global Burden, Trends, and Inequalities of Infections from 1990 to 2021 and Projections to 2040: A Systematic Analysis.1990年至2021年感染的全球负担、趋势和不平等状况以及到2040年的预测：一项系统分析
Antibiotics (Basel). 2025 Jun 27;14(7):652. doi: 10.3390/antibiotics14070652.
2
Molecular Epidemiology of Infections in Patients Hospitalized in 2017-2019 at the Central Teaching Hospital of Medical University of Lodz, Central Poland.2017 - 2019年波兰中部罗兹医科大学中央教学医院住院患者感染的分子流行病学
Antibiotics (Basel). 2025 Feb 21;14(3):219. doi: 10.3390/antibiotics14030219.
3
Multi-omics analysis reveals interactions between host and microbes in Bama miniature pigs during weaning.
多组学分析揭示了巴马小型猪断奶期间宿主与微生物之间的相互作用。
Front Microbiol. 2024 Dec 11;15:1482925. doi: 10.3389/fmicb.2024.1482925. eCollection 2024.
4
Therapeutics involved in managing initial and recurrent infection: An updated literature review.治疗初发和复发性感染的疗法：文献综述更新
World J Gastrointest Pharmacol Ther. 2024 Sep 5;15(5):95467. doi: 10.4292/wjgpt.v15.i5.95467.
5
Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches.肠道微生态失调的研究进展：炎症性疾病、肥胖症及相关修复策略
Int J Mol Sci. 2024 Sep 8;25(17):9715. doi: 10.3390/ijms25179715.
6
[Analysis of infection characteristics and risk factors in patients hospitalized for diarrhea in 3 university hospitals in a mid-south city of China].[中国中南部某城市3家大学医院腹泻住院患者感染特征及危险因素分析]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 May 20;44(5):998-1003. doi: 10.12122/j.issn.1673-4254.2024.05.23.
7
Gut microbiome changes in mouse, Mongolian gerbil, and hamster models following challenge.小鼠、长爪沙鼠和仓鼠模型在受到攻击后肠道微生物群的变化。
Front Microbiol. 2024 Apr 4;15:1368194. doi: 10.3389/fmicb.2024.1368194. eCollection 2024.
8
Infection: Diagnosis and Treatment Challenges.感染：诊断与治疗挑战
Pathogens. 2024 Jan 27;13(2):118. doi: 10.3390/pathogens13020118.
9
Host Immune Responses to Infection and Potential Novel Therapeutic Approaches.宿主对感染的免疫反应及潜在的新型治疗方法。
Trop Med Infect Dis. 2023 Nov 23;8(12):506. doi: 10.3390/tropicalmed8120506.
10
Analysis of risk factors for community-acquired diarrhea in children: a case-control study in Chenzhou, China.儿童社区获得性腹泻危险因素分析：中国郴州的一项病例对照研究
Transl Pediatr. 2023 Nov 28;12(11):2053-2061. doi: 10.21037/tp-23-448. Epub 2023 Nov 17.